Michael G. Kauffman
Overview
Michael G. Kauffman received an average of $3M in total compensation, including $493K in salary, at Karyopharm Therapeutics from 2012 to 2021.
2021Karyopharm TherapeuticsSenior Clinical Advisor and Former Chief Executive Officer
2020Karyopharm TherapeuticsChief Executive Officer
2019Karyopharm TherapeuticsChief Executive Officer
2018Karyopharm TherapeuticsChief Executive Officer
2017Karyopharm TherapeuticsChief Executive Officer
2016Karyopharm TherapeuticsChief Executive Officer
2015Karyopharm TherapeuticsChief Executive Officer
2014Karyopharm TherapeuticsChief Executive Officer
2013Karyopharm TherapeuticsChief Executive Officer
2012Karyopharm TherapeuticsChief Executive Officer
Source: SEC filings on April 8, 2022, April 7, 2021, April 9, 2020, April 19, 2019, April 27, 2018, April 28, 2017, April 29, 2016, April 7, 2015, and April 28, 2014.
Related executives
We found ten more executives who work or worked at Karyopharm Therapeutics.
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Chief Development Officer
Christopher Primiano
Karyopharm Therapeutics
General Counsel
Anand Varadan
Karyopharm Therapeutics
Executive Vice President, Chief Commercial Officer
Michael MSM
Karyopharm Therapeutics
Chief Financial Officer
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019